Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharm Biopharm ; 166: 87-93, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34102300

ABSTRACT

Injection of biological molecules into the intravitreous humor is of increasing interest for the treatment of posterior segment eye diseases such as age-related degenerative macular degeneration. The injection volume is limited by an increase in intraocular pressure (IOP) and 50-100 µL are typically used for most intravitreally (IVT) applied commercial products. Direct measurement of IOP is difficult and has not been studied dependent on solution properties and injection rates. We used an instrumental set-up to study IOP ex vivo using healthy enucleated porcine eyes. IOP was determined as a function of injection volume for viscosities between 1 and 100 mPas, injection rates of 0.1, 1, and 1.5 mL/min, and needle length and diameter (27/30G and 0.5/0.75″) using Dextran solutions. IOP increased exponentially for injection volumes larger than 100 µL. We did not observe differences in IOP dependent on viscosity, injection rate, and needle diameter. However, variability increased significantly for injection volumes larger than 100 µL and, unexpectedly, declined with higher viscosities. We demonstrate that the exponential increase in IOP is not reflected by injection force measurements for typical configurations that are used for IVT application. The present findings may guide injection volumes for intravitreal injection and inform injection force considerations during technical drug product development.


Subject(s)
Intraocular Pressure , Intravitreal Injections , Pharmaceutical Solutions , Posterior Eye Segment , Retinal Diseases , Viscosity , Animals , Dextrans/pharmacology , Disease Models, Animal , Drug Delivery Systems/methods , Equipment Design , Intravitreal Injections/instrumentation , Intravitreal Injections/methods , Needles , Organ Size , Pharmaceutical Solutions/chemistry , Pharmaceutical Solutions/pharmacology , Plasma Substitutes/pharmacology , Posterior Eye Segment/pathology , Posterior Eye Segment/physiology , Retinal Diseases/drug therapy , Retinal Diseases/physiopathology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...